China Jieya reported operating revenue of 124 million yuan in the first quarter of 2025

  In the first quarter of 2025, Tongling Jieya Biotechnology Co., Ltd. reported operating revenue of about 124 million yuan, a 4.62% year-on-year decrease. Its net profit attributable to shareholders was approximately 10.0627 million yuan, down by 27.61% year-on-year. The basic earnings per share were 0.13 yuan/share, representing a 23.53% year-on-year decline.